Advanced antibiotic compounds tailored for the United Arab Emirates market.
The United Arab Emirates (UAE) has rapidly emerged as a sophisticated hub for pharmaceutical manufacturing and distribution in the Middle East. Under the strategic vision of the UAE Government, particularly the "Dubai Industrial Strategy 2030" and the "Operation 300bn" initiative, the nation is aggressively reducing its reliance on imported medicines by fostering a world-class local manufacturing ecosystem. As a premier Antibiotic Drugs Factory & Supplier, we recognize that the UAE serves as a gateway to the GCC, Africa, and South Asia.
The UAE pharmaceutical market is projected to reach over $4.7 billion by 2025. This growth is driven by high-quality healthcare infrastructure, increasing chronic disease prevalence, and a growing population. For antibiotic drugs, the demand is particularly high due to the region's climate-specific infectious diseases and the massive scale of the livestock and poultry sectors in Abu Dhabi and Al Ain.
The Ministry of Health and Prevention (MoHAP) in the UAE enforces some of the world’s most stringent GMP (Good Manufacturing Practice) standards. This ensures that every antibiotic drug, whether used for human clinical purposes or veterinary applications, meets the highest safety and efficacy profiles. Our collaboration with UAE-based distributors allows us to navigate these regulatory pathways, ensuring that Hangzhou Jeci Biochem Technology products provide the reliability expected by Emirati healthcare professionals.
Integrating Artificial Intelligence into Bio-Chemical Synthesis for superior drug purity.
In the modern era of medicine, the production of antibiotics like Tylosin, Florfenicol, and Enrofloxacin requires more than just traditional chemical synthesis. At our facility, we employ AI-driven predictive modeling to optimize molecular stability and bioavailability. This technological edge is particularly relevant for the UAE's "Smart City" initiatives, where healthcare is increasingly data-driven.
The use of AI in our R&D allows us to simulate drug-pathogen interactions, ensuring that our Broad-Spectrum Antibiotics remain effective against evolving bacterial strains. This is a critical factor for the UAE’s biosecurity strategy, helping local farmers and veterinarians manage infectious diseases in poultry and livestock with precision-targeted treatments.
The UAE has a profound cultural and economic connection to camel breeding and racing. Antibiotics such as Gentamicin and Ivermectin are vital for maintaining the health of these prize animals. Our formulations are designed to withstand the high temperatures of the desert, ensuring stability during transport to remote farms in the Western Region.
Al Ain is the heart of the UAE's food security and poultry production. Massive poultry farms require constant supply of high-grade antibiotics like Ampicillin Trihydrate and Cefquinome Sulfate to prevent large-scale outbreaks of respiratory and intestinal infections in the arid climate.
Beyond direct animal application, our pharmaceutical intermediates serve the growing industrial chemical sector in Jebel Ali and ICAD (Industrial City of Abu Dhabi). We provide the raw chemical foundations required for localized drug compounding and specialty chemical manufacturing, aligning with the UAE's goal of becoming a global manufacturing powerhouse.
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
The future of antibiotic supply in the UAE is shifting towards Sustainability and Green Chemistry. As part of the UAE’s Net Zero 2050 goal, pharmaceutical suppliers are expected to minimize environmental impact. Hangzhou Jeci Biochem is pioneering eco-friendly synthesis methods for our antibiotic range, reducing waste while maintaining 99% purity.
Furthermore, the rise of Telemedicine and E-pharmacies in Dubai and Abu Dhabi is changing the distribution model. Our supply chain is optimized for high-speed logistics, utilizing the world-class ports of Khalifa and Jebel Ali to ensure that critical antibiotic drugs are available on-demand, minimizing lead times for hospitals and veterinary clinics.
A full range of GMP-certified products for UAE industrial and veterinary requirements.
Quality Guaranteed | GMP Compliance | Global Logistics | Technical Support
Request a Quotation Today
SJ medical
